Latest UK-focused news and updates.
Recent reports indicate a slight easing in the downturn of the UK housing market, although overall sentiment among surveyors remains fragile. This development comes amid ongoing economic challenges, including rising interest rates and inflation concerns that have affected buyer confidence.
In related news, Brent crude oil prices have dipped slightly below $78 a barrel, while most Asian stock markets have shown signs of recovery. These fluctuations in the global market may have implications for the UK economy, particularly in sectors reliant on energy prices.
On the pharmaceutical front, GSK, the UK's second-largest drugmaker, is facing setbacks following the termination of its neuroscience collaboration with Californian biotech firm Alector. This decision comes after both companies experienced failures in clinical trials for two experimental antibody drugs. The termination marks a significant blow to Alector, which had previously secured a substantial upfront payment from GSK as part of their partnership.
Despite these challenges, the CARDIO-TTRansform trial, which assessed a new gene silencer treatment for cardiovascular conditions, has provided insights that could enhance scientific understanding of treatment options for patients suffering from progressive heart diseases.
As the UK navigates these economic and healthcare challenges, the resilience of the housing market and the pharmaceutical sector will be closely monitored by analysts and investors alike.
Source: www.theguardian.com – https://www.theguardian.com/business/live/2026/jul/09/stock-markets-oil-uk-house-prices-business-news-updates